BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6442051)

  • 1. [Parenteral gold therapy (Tauredon) in chronic polyarthritis].
    Tausch G; Gaismayer K
    Wien Klin Wochenschr Suppl; 1984; 156():19-21. PubMed ID: 6442051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Side effects of gold salt therapy in patients with rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(2):25-8. PubMed ID: 1366149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of 6 months of treatment with Tauredon on clinical indicators in rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(1):27-31. PubMed ID: 1366142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of Tauredon on the development of non-specific indicators of inflammatory activity in patients with rheumatoid arthritis].
    Vlak T; Jajić Z
    Reumatizam; 1992; 39(1):19-22. PubMed ID: 1366140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of gold salts on rheumatoid factor dynamics in patients with rheumatoid arthritis].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(1):11-3. PubMed ID: 1366138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complement (C3 and C4) in patients with rheumatoid arthritis during 6 months of treatment with gold salts].
    Vlak T; Jajić I
    Reumatizam; 1992; 39(1):7-10. PubMed ID: 1366144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Tauredon treatment of rheumatoid arthritis patients: its efficacy and tolerance when used long term].
    Murav'ev IuV; Nasonova VA; Ivanova MM; Taukumova LA
    Ter Arkh; 1996; 68(5):16-8. PubMed ID: 9082589
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gold therapy in chronic polyarthritis. Differentiation of allergic and toxic side effects].
    Bene E; Megyeri A; Györi J
    Z Rheumatol; 1980; 39(3-4):109-16. PubMed ID: 6448525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conspicuous accumulation of membranous glomerulonephritis following gold therapy in chronic polyarthritis--a side effect of a new preparation?].
    Burger HR; Briner J; Spycher MA
    Schweiz Med Wochenschr; 1979 Mar; 109(12):423-31. PubMed ID: 106466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of low doses of sodium aurothiomalate in the treatment of rheumatoid arthritis. Current trends in basic therapy].
    Bianucci G; Maddali Bongi S; Cencetti A; Curradi C
    Clin Ter; 1996 Dec; 147(12):609-20. PubMed ID: 9296920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind one year clinical trial comparing alclofenac with gold in rheumatoid arthritis.
    Kadir N; Grayson MF; Campbell ED
    Ann Clin Res; 1983; 15(1):4-9. PubMed ID: 6134490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of rheumatoid polyarthritis with methotrexate in Dakar: efficacy, tolerance and cost].
    Ka MM; Diallo S; Ka EF; Diop BM; Pouye A; Mbengue M; Leye A; Diouf B; Diop TM
    Sante; 2000; 10(1):65-8. PubMed ID: 10827366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver toxicity profile in gold-treated Egyptian rheumatoid arthritis patients.
    Koryem HK; Taha KM; Ibrahim IK; Younes LK
    Int J Clin Pharmacol Res; 1998; 18(1):31-7. PubMed ID: 9604732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences to date with oral gold therapy].
    Zeidler H
    Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.